-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Syndax Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
- Syndax Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$74.2M, a 49.4% decline year-over-year.
- Syndax Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$288M, a 66.6% decline year-over-year.
- Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$230M, a 51.5% decline from 2022.
- Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$152M, a 679% decline from 2021.
- Syndax Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was $26.2M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)